MicroPort NeuroTech Limited (2172.HK)
2172.HK Stock Price Chart
Explore MicroPort NeuroTech Limited interactive price chart. Choose custom timeframes to analyze 2172.HK price movements and trends.
2172.HK Company Profile
Discover essential business fundamentals and corporate details for MicroPort NeuroTech Limited (2172.HK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
15 Jul 2022
Employees
527.00
Website
https://www.medneurotech.comCEO
Zhiyong Xie
Description
MicroPort NeuroTech Limited engages in the research and development, production, and sale of neuro-interventional medical devices in the People's Republic of China and internationally. It offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; Tubridge, a flow-diverting stent; Willis, an intracranial stent graft system; and Rebridge, an intracranial visualized stent for use in the treatment of hemorrhagic stroke. The company also provides APOLLO, an intracranial arterial stent system to treat intracranial atherosclerotic disease; and Bridge, a rapamycin target eluting vertebral artery stent system to treat cerebral atherosclerotic stenosis. In addition, it offers Neurohawk, a stent thrombectomy device; Tigertriever, an adjustable stent retriever for use in the treatment of acute ischemic stroke. The company was founded in 2004 and is headquartered in Shanghai, the People's Republic of China.
2172.HK Financial Timeline
Browse a chronological timeline of MicroPort NeuroTech Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Mar 2026
Upcoming earnings on 24 Mar 2026
Dividend declared on 10 Sept 2025
A dividend of $0.05 per share was announced, adjusted to $0.05. The dividend will be paid on 26 Sept 2025.
Earnings released on 27 Aug 2025
EPS came in at $0.18 , while revenue for the quarter reached $419.61M .
Earnings released on 27 Aug 2025
EPS came in at $0.18 , while revenue for the quarter reached $419.61M .
Dividend declared on 2 Jul 2025
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 22 Aug 2025.
Earnings released on 26 Mar 2025
EPS came in at $0.11 , while revenue for the quarter reached $195.60M .
Earnings released on 31 Dec 2024
EPS came in at $0.10 , while revenue for the quarter reached $188.05M .
Dividend declared on 10 Sept 2024
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 26 Sept 2024.
Earnings released on 28 Aug 2024
EPS came in at $0.13 , while revenue for the quarter reached $221.05M .
Earnings released on 30 Jun 2024
EPS came in at $0.13 , while revenue for the quarter reached $219.09M .
Dividend declared on 28 Jun 2024
A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 22 Aug 2024.
Earnings released on 31 Dec 2023
EPS came in at $0.15 , while revenue for the quarter reached $396.77M .
Earnings released on 30 Sept 2023
EPS came in at $0.07 , while revenue for the quarter reached $195.98M .
Earnings released on 30 Jun 2023
EPS came in at $0.12 , while revenue for the quarter reached $338.08M .
Earnings released on 31 Mar 2023
EPS came in at $0.06 falling short of the estimated $0.12 by -47.22%, while revenue for the quarter reached $170.85M , missing expectations by -47.16%.
Earnings released on 29 Mar 2023
Earnings released on 31 Dec 2022
EPS came in at $0.14 , while revenue for the quarter reached $383.06M .
Earnings released on 30 Jun 2022
EPS came in at -$0.19 , while revenue for the quarter reached $248.51M .
2172.HK Stock Performance
Access detailed 2172.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.